1. Home
  2. AER vs ROIV Comparison

AER vs ROIV Comparison

Compare AER & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AerCap Holdings N.V.

AER

AerCap Holdings N.V.

HOLD

Current Price

$135.14

Market Cap

22.9B

ML Signal

HOLD

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$28.28

Market Cap

20.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AER
ROIV
Founded
1995
2014
Country
Ireland
United Kingdom
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.9B
20.7B
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
AER
ROIV
Price
$135.14
$28.28
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
8
Target Price
$150.29
$27.56
AVG Volume (30 Days)
1.4M
4.7M
Earning Date
01-01-0001
05-11-2026
Dividend Yield
1.20%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$29,053,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.53
$385.85
P/E Ratio
$7.27
N/A
Revenue Growth
N/A
N/A
52 Week Low
$85.57
$8.73
52 Week High
$154.94
$30.33

Technical Indicators

Market Signals
Indicator
AER
ROIV
Relative Strength Index (RSI) 37.61 54.64
Support Level $129.85 $26.94
Resistance Level $138.34 N/A
Average True Range (ATR) 4.30 1.01
MACD -1.63 -0.26
Stochastic Oscillator 14.96 38.46

Price Performance

Historical Comparison
AER
ROIV

About AER AerCap Holdings N.V.

AerCap Holdings NV is an aircraft leasing company. Its activities include leasing, financing, sales, and management of commercial aircraft and engines. It also provides aircraft asset management and corporate services to securitization vehicles, joint ventures, and other third parties. It has one business segment: leasing, financing, sales, and management of commercial flight equipment (Commercial Flight Equipment Segment). Through its subsidiary, the group also provides engine leasing, certified aircraft engines, airframes, and engine parts. Its geographical segments include China, the United States, and Other countries.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: